SIC 3841 – Surgical and Medical Instruments and Apparatus
Valuation | |
---|---|
Market Cap ($M) | 402.17 |
Enterprise Value ($M) | 369.76 |
Book Value ($M) | 68.75 |
Book Value / Share | 2.06 |
Price / Book | 5.85 |
NCAV ($M) | 65.92 |
NCAV / Share | 1.97 |
Price / NCAV | 6.10 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.38 |
Return on Assets (ROA) | -0.73 |
Return on Equity (ROE) | -1.80 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 10.88 |
Current Ratio | 12.01 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 73.76 |
Assets | 76.59 |
Liabilities | 7.84 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 37.20 |
Operating Income | -12.41 |
Net Income | -26.39 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.68 |
Cash from Investing | -0.98 |
Cash from Financing | 39.41 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Rosalind Advisors, Inc. | 9.90 | 141.00 | |
13G/A | Vivo Opportunity Fund Holdings, L.P. | 5.30 | -36.92 | |
13G/A | Biotechnology Value Fund L P | 3.60 | -55.45 | |
13G/A | Hirschman Orin | 4.60 | -4.37 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
44,001 | 306,967 | 14.33 | |
38,470 | 182,341 | 21.10 | |
54,430 | 250,377 | 21.74 | |
41,267 | 248,531 | 16.60 | |
(click for more detail) |
Similar Companies | |
---|---|
COCH – Envoy Medical, Inc. | CODX – Co-Diagnostics, Inc. |
CTSO – Cytosorbents Corporation | DRIO – DarioHealth Corp. |
ECOR – electroCore, Inc. |